Cardiometabolic health improvements upon dietary intervention are driven by tissue-specific insulin resistance phenotype : A precision nutrition trial
Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved..
Precision nutrition based on metabolic phenotype may increase the effectiveness of interventions. In this proof-of-concept study, we investigated the effect of modulating dietary macronutrient composition according to muscle insulin-resistant (MIR) or liver insulin-resistant (LIR) phenotypes on cardiometabolic health. Women and men with MIR or LIR (n = 242, body mass index [BMI] 25-40 kg/m2, 40-75 years) were randomized to phenotype diet (PhenoDiet) group A or B and followed a 12-week high-monounsaturated fatty acid (HMUFA) diet or low-fat, high-protein, and high-fiber diet (LFHP) (PhenoDiet group A, MIR/HMUFA and LIR/LFHP; PhenoDiet group B, MIR/LFHP and LIR/HMUFA). PhenoDiet group B showed no significant improvements in the primary outcome disposition index, but greater improvements in insulin sensitivity, glucose homeostasis, serum triacylglycerol, and C-reactive protein compared with PhenoDiet group A were observed. We demonstrate that modulating macronutrient composition within the dietary guidelines based on tissue-specific insulin resistance (IR) phenotype enhances cardiometabolic health improvements. Clinicaltrials.gov registration: NCT03708419, CCMO registration NL63768.068.17.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:35 |
|---|---|
| Enthalten in: |
Cell metabolism - 35(2023), 1 vom: 03. Jan., Seite 71-83.e5 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Trouwborst, Inez [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 13.01.2023 Date Revised 13.02.2023 published: Print ClinicalTrials.gov: NCT03708419 Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.cmet.2022.12.002 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM35110495X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM35110495X | ||
| 003 | DE-627 | ||
| 005 | 20231226050535.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.cmet.2022.12.002 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1170.xml |
| 035 | |a (DE-627)NLM35110495X | ||
| 035 | |a (NLM)36599304 | ||
| 035 | |a (PII)S1550-4131(22)00539-3 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Trouwborst, Inez |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Cardiometabolic health improvements upon dietary intervention are driven by tissue-specific insulin resistance phenotype |b A precision nutrition trial |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 13.01.2023 | ||
| 500 | |a Date Revised 13.02.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a ClinicalTrials.gov: NCT03708419 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved. | ||
| 520 | |a Precision nutrition based on metabolic phenotype may increase the effectiveness of interventions. In this proof-of-concept study, we investigated the effect of modulating dietary macronutrient composition according to muscle insulin-resistant (MIR) or liver insulin-resistant (LIR) phenotypes on cardiometabolic health. Women and men with MIR or LIR (n = 242, body mass index [BMI] 25-40 kg/m2, 40-75 years) were randomized to phenotype diet (PhenoDiet) group A or B and followed a 12-week high-monounsaturated fatty acid (HMUFA) diet or low-fat, high-protein, and high-fiber diet (LFHP) (PhenoDiet group A, MIR/HMUFA and LIR/LFHP; PhenoDiet group B, MIR/LFHP and LIR/HMUFA). PhenoDiet group B showed no significant improvements in the primary outcome disposition index, but greater improvements in insulin sensitivity, glucose homeostasis, serum triacylglycerol, and C-reactive protein compared with PhenoDiet group A were observed. We demonstrate that modulating macronutrient composition within the dietary guidelines based on tissue-specific insulin resistance (IR) phenotype enhances cardiometabolic health improvements. Clinicaltrials.gov registration: NCT03708419, CCMO registration NL63768.068.17 | ||
| 650 | 4 | |a Randomized Controlled Trial | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a cardiometabolic health | |
| 650 | 4 | |a dietary intervention trial | |
| 650 | 4 | |a glucose homeostasis | |
| 650 | 4 | |a metabotyping | |
| 650 | 4 | |a precision nutrition | |
| 650 | 4 | |a tissue-specific insulin resistance | |
| 650 | 7 | |a Insulin |2 NLM | |
| 700 | 1 | |a Gijbels, Anouk |e verfasserin |4 aut | |
| 700 | 1 | |a Jardon, Kelly M |e verfasserin |4 aut | |
| 700 | 1 | |a Siebelink, Els |e verfasserin |4 aut | |
| 700 | 1 | |a Hul, Gabby B |e verfasserin |4 aut | |
| 700 | 1 | |a Wanders, Lisa |e verfasserin |4 aut | |
| 700 | 1 | |a Erdos, Balázs |e verfasserin |4 aut | |
| 700 | 1 | |a Péter, Szabolcs |e verfasserin |4 aut | |
| 700 | 1 | |a Singh-Povel, Cécile M |e verfasserin |4 aut | |
| 700 | 1 | |a de Vogel-van den Bosch, Johan |e verfasserin |4 aut | |
| 700 | 1 | |a Adriaens, Michiel E |e verfasserin |4 aut | |
| 700 | 1 | |a Arts, Ilja C W |e verfasserin |4 aut | |
| 700 | 1 | |a Thijssen, Dick H J |e verfasserin |4 aut | |
| 700 | 1 | |a Feskens, Edith J M |e verfasserin |4 aut | |
| 700 | 1 | |a Goossens, Gijs H |e verfasserin |4 aut | |
| 700 | 1 | |a Afman, Lydia A |e verfasserin |4 aut | |
| 700 | 1 | |a Blaak, Ellen E |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cell metabolism |d 2005 |g 35(2023), 1 vom: 03. Jan., Seite 71-83.e5 |w (DE-627)NLM156885433 |x 1932-7420 |7 nnns |
| 773 | 1 | 8 | |g volume:35 |g year:2023 |g number:1 |g day:03 |g month:01 |g pages:71-83.e5 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.cmet.2022.12.002 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 35 |j 2023 |e 1 |b 03 |c 01 |h 71-83.e5 | ||